Latest filing published 09 Dec 2022 for BIO-TECHNE Corp, €24k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Brenda S. Furlow on record concern BIO-TECHNE Corp, in the capacity of senior executive. In total, 12 filings cover trades dated from 8 August 2021 to 7 December 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 9 December 2022, the filings show an option exercise worth €24k in BIO-TECHNE Corp. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations